Marking this achievement, the three scientific and industrial research committees (CSIRs) in Hyderabad – IICT, CCMB and NGRI – have collaborated to organize a two-day “CSIR Startup Meeting” at Zahir Memorial School on April 22 and 23 at Habsiguda. More than 200 startups will showcase their products and technologies.
“CCMB and IICT are providing nurturing sites for newcomers like us, as all startups have no capital to buy instruments or execute ideas. These institutions support us from the very beginning.
CCMB’s ATAL Incubation Center has helped over 160 startups take off and found a place in the growing pharmaceutical market.
Their company is developing monoclonal antibodies for cancer treatment. “We are trying to develop low-cost platform technologies to enable end users or pharmaceutical companies to access products at very low costs,” Dr. Rao said.
Currently, the company is based in IICT and is engaged in animal mRNA vaccine technology to improve meat production in sheep and goats. “At the meeting, we will present biopharmaceuticals produced using new processes developed and patented by Oncosimis Biotech,” said Dr. Reddy.
CCMB and IICT incubate another promising startup, Althion, and have been providing Ulta-Pure water for kidney dialysis. “But in India, in India, water purification for dialysis is largely unregulated… We found this critical problem and discovered a membrane technology developed by IICT in laboratory-grade ultrapure water,” said Surya Rao, founder of Althion.
“It all has something to do with good people and a good network. CCMB has exposed us to various activities. We work on behalf of our products, at national and international events. They have helped us brand and present products. It has also helped our investors connect and invest,” Suresh Suresh Susurla, co-founder of Startoon Labs.
The company has been incubated in CCMB for three years and has received brand and marketing and investor assistance from AIC CCMB. “We have a wearable medical device called Pheezee for rehabilitation, physiotherapy and combined health care. We’re also expanding in the United States,” Susurla said.
